Table of Contents Author Guidelines Submit a Manuscript
Neural Plasticity
Volume 2016 (2016), Article ID 5238730, 12 pages
http://dx.doi.org/10.1155/2016/5238730
Research Article

Blockade of Toll-Like Receptors (TLR2, TLR4) Attenuates Pain and Potentiates Buprenorphine Analgesia in a Rat Neuropathic Pain Model

Department of Pain Pharmacology, Institute of Pharmacology, Polish Academy of Sciences, 31-343 Krakow, Poland

Received 7 May 2015; Revised 7 September 2015; Accepted 20 September 2015

Academic Editor: Shao-Jun Tang

Copyright © 2016 Agnieszka M. Jurga et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. R. H. Dworkin, D. C. Turk, N. P. Katz et al., “Evidence-based clinical trial design for chronic pain pharmacotherapy: a blueprint for ACTION,” Pain, vol. 152, no. 3, supplement, pp. S107–S115, 2011. View at Publisher · View at Google Scholar · View at Scopus
  2. E. Kalso, J. E. Edwards, R. A. Moore, and H. J. McQuay, “Opioids in chronic non-cancer pain: systematic review of efficacy and safety,” Pain, vol. 112, no. 3, pp. 372–380, 2004. View at Publisher · View at Google Scholar · View at Scopus
  3. D. Kim, M. A. Kim, I.-H. Cho et al., “A critical role of toll-like receptor 2 in nerve injury-induced spinal cord glial cell activation and pain hypersensitivity,” The Journal of Biological Chemistry, vol. 282, no. 20, pp. 14975–14983, 2007. View at Publisher · View at Google Scholar · View at Scopus
  4. F. Y. Tanga, N. Nutile-McMenemy, and J. A. DeLeo, “The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy,” Proceedings of the National Academy of Sciences of the United States of America, vol. 102, no. 16, pp. 5856–5861, 2005. View at Publisher · View at Google Scholar · View at Scopus
  5. K. Miyake, “Innate immune sensing of pathogens and danger signals by cell surface Toll-like receptors,” Seminars in Immunology, vol. 19, no. 1, pp. 3–10, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. R. E. Sorge, M. L. LaCroix-Fralish, A. H. Tuttle et al., “Spinal cord Toll-like receptor 4 mediates inflammatory and neuropathic hypersensitivity in male but not female mice,” The Journal of Neuroscience, vol. 31, no. 43, pp. 15450–15454, 2011. View at Publisher · View at Google Scholar · View at Scopus
  7. T. Liu, Y.-J. Gao, and R.-R. Ji, “Emerging role of Toll-like receptors in the control of pain and itch,” Neuroscience Bulletin, vol. 28, no. 2, pp. 131–144, 2012. View at Publisher · View at Google Scholar · View at Scopus
  8. D. Hwang, “Modulation of the expression of cyclooxygenase-2 by fatty acids mediated through toll-like receptor 4-derived signaling pathways,” The FASEB Journal, vol. 15, no. 14, pp. 2556–2564, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. J. Y. Lee, K. H. Sohn, S. H. Rhee, and D. Hwang, “Saturated fatty acids, but not unsaturated fatty acids, induce the expression of cyclooxygenase-2 mediated through Toll-like receptor 4,” The Journal of Biological Chemistry, vol. 276, no. 20, pp. 16683–16689, 2001. View at Publisher · View at Google Scholar · View at Scopus
  10. C. A. Christianson, D. S. Dumlao, J. A. Stokes et al., “Spinal TLR4 mediates the transition to a persistent mechanical hypersensitivity after the resolution of inflammation in serum-transferred arthritis,” Pain, vol. 152, no. 12, pp. 2881–2891, 2011. View at Publisher · View at Google Scholar · View at Scopus
  11. X. Li, X.-W. Wang, X.-M. Feng, W.-J. Zhou, Y.-Q. Wang, and Q.-L. Mao-Ying, “Stage-dependent anti-allodynic effects of intrathecal Toll-like receptor 4 antagonists in a rat model of cancer induced bone pain,” The Journal of Physiological Sciences, vol. 63, no. 3, pp. 203–209, 2013. View at Publisher · View at Google Scholar · View at Scopus
  12. Y. Li, H. Zhang, H. Zhang, A. K. Kosturakis, A. B. Jawad, and P. M. Dougherty, “Toll-like receptor 4 signaling contributes to paclitaxel-induced peripheral neuropathy,” The Journal of Pain, vol. 15, no. 7, pp. 712–725, 2014. View at Publisher · View at Google Scholar · View at Scopus
  13. M. R. Hutchinson, Y. Zhang, K. Brown et al., “Non-stereoselective reversal of neuropathic pain by naloxone and naltrexone: involvement of toll-like receptor 4 (TLR4),” European Journal of Neuroscience, vol. 28, no. 1, pp. 20–29, 2008. View at Publisher · View at Google Scholar · View at Scopus
  14. K. A. Kigerl, J. P. D. R. Vaccari, W. D. Dietrich, P. G. Popovich, and R. W. Keane, “Pattern recognition receptors and central nervous system repair,” Experimental Neurology, vol. 258, pp. 5–16, 2014. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Przewlocki and B. Przewlocka, “Opioids in neuropathic pain,” Current Pharmaceutical Design, vol. 11, no. 23, pp. 3013–3025, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. J. Mika, M. Zychowska, K. Popiolek-Barczyk, E. Rojewska, and B. Przewlocka, “Importance of glial activation in neuropathic pain,” European Journal of Pharmacology, vol. 716, no. 1–3, pp. 106–119, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. L. N. Eidson and A. Z. Murphy, “Blockade of Toll-like receptor 4 attenuates morphine tolerance and facilitates the pain relieving properties of morphine,” The Journal of Neuroscience, vol. 33, no. 40, pp. 15952–15963, 2013. View at Publisher · View at Google Scholar · View at Scopus
  18. L. Bai, C. Zhai, K. Han et al., “Toll-like receptor 4-mediated nuclear factor-κB activation in spinal cord contributes to chronic morphine-induced analgesic tolerance and hyperalgesia in rats,” Neuroscience Bulletin, vol. 30, no. 6, pp. 936–948, 2014. View at Publisher · View at Google Scholar · View at Scopus
  19. J. L. Johnson, P. E. Rolan, M. E. Johnson et al., “Codeine-induced hyperalgesia and allodynia: investigating the role of glial activation,” Translational Psychiatry, vol. 4, no. 11, article e482, 2014. View at Publisher · View at Google Scholar
  20. T. A. Mattioli, H. Leduc-Pessah, G. Skelhorne-Gross et al., “Toll-like receptor 4 mutant and null mice retain morphine-induced tolerance, hyperalgesia, and physical dependence,” PLoS ONE, vol. 9, no. 5, Article ID e97361, 2014. View at Publisher · View at Google Scholar
  21. M. Zimmermann, “Ethical guidelines for investigations of experimental pain in conscious animals,” Pain, vol. 16, no. 2, pp. 109–110, 1983. View at Publisher · View at Google Scholar · View at Scopus
  22. T. L. Yaksh and T. A. Rudy, “Analgesia mediated by a direct spinal action of narcotics,” Science, vol. 192, no. 4246, pp. 1357–1358, 1976. View at Publisher · View at Google Scholar · View at Scopus
  23. G. J. Bennett and Y.-K. Xie, “A peripheral mononeuropathy in rat that produces disorders of pain sensation like those seen in man,” Pain, vol. 33, no. 1, pp. 87–107, 1988. View at Publisher · View at Google Scholar · View at Scopus
  24. S. S. Lewis, M. R. Hutchinson, N. Rezvani et al., “Evidence that intrathecal morphine-3-glucuronide may cause pain enhancement via toll-like receptor 4/MD-2 and interleukin-1β,” Neuroscience, vol. 165, no. 2, pp. 569–583, 2010. View at Publisher · View at Google Scholar · View at Scopus
  25. W. Makuch, J. Mika, E. Rojewska, M. Zychowska, and B. Przewlocka, “Effects of selective and non-selective inhibitors of nitric oxide synthase on morphine- and endomorphin-1-induced analgesia in acute and neuropathic pain in rats,” Neuropharmacology, vol. 75, pp. 445–457, 2013. View at Publisher · View at Google Scholar · View at Scopus
  26. J. Mika, M. Osikowicz, W. Makuch, and B. Przewlocka, “Minocycline and pentoxifylline attenuate allodynia and hyperalgesia and potentiate the effects of morphine in rat and mouse models of neuropathic pain,” European Journal of Pharmacology, vol. 560, no. 2-3, pp. 142–149, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. P. Chomczynski and N. Sacchi, “Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction,” Analytical Biochemistry, vol. 162, no. 1, pp. 156–159, 1987. View at Publisher · View at Google Scholar · View at Scopus
  28. E. Rojewska, K. Popiolek-Barczyk, A. M. Jurga, W. Makuch, B. Przewlocka, and J. Mika, “Involvement of pro- and antinociceptive factors in minocycline analgesia in rat neuropathic pain model,” Journal of Neuroimmunology, vol. 277, no. 1-2, pp. 57–66, 2014. View at Publisher · View at Google Scholar · View at Scopus
  29. I. Bettoni, F. Comelli, C. Rossini et al., “Glial TLR4 receptor as new target to treat neuropathic pain: efficacy of a new receptor antagonist in a model of peripheral nerve injury in mice,” Glia, vol. 56, no. 12, pp. 1312–1319, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. J. Mika, “Modulation of microglia can attenuate neuropathic pain symptoms and enhance morphine effectiveness,” Pharmacological Reports, vol. 60, no. 3, pp. 297–307, 2008. View at Google Scholar · View at Scopus
  31. J. H. Hayward and S. J. Lee, “A decade of research on TLR2 discovering its pivotal role in glial activation and neuroinflammation in neurodegenerative diseases,” Experimental Neurobiology, vol. 23, no. 2, pp. 138–147, 2014. View at Publisher · View at Google Scholar
  32. S. Lehnardt, L. Massillon, P. Follett et al., “Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway,” Proceedings of the National Academy of Sciences of the United States of America, vol. 100, no. 14, pp. 8514–8519, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. F.-X. Wu, J.-J. Bian, X.-R. Miao et al., “Intrathecal siRNA against Toll-like receptor 4 reduces nociception in a rat model of neuropathic pain,” International Journal of Medical Sciences, vol. 7, no. 5, pp. 251–259, 2010. View at Google Scholar · View at Scopus
  34. J.-E. Yan, W. Yuan, X. Lou, and T. Zhu, “Streptozotocin-induced diabetic hyperalgesia in rats is associated with upregulation of toll-like receptor 4 expression,” Neuroscience Letters, vol. 526, no. 1, pp. 54–58, 2012. View at Publisher · View at Google Scholar · View at Scopus
  35. Y. P. Zhang, C. Y. Song, Y. Yuan et al., “Diabetic neuropathic pain development in type 2 diabetic mouse model and the prophylactic and therapeutic effects of coenzyme Q10,” Neurobiology of Disease, vol. 58, pp. 169–178, 2013. View at Publisher · View at Google Scholar · View at Scopus
  36. X. Q. Shi, H. Zekki, and J. Zhang, “The role of TLR2 in nerve injury-induced neuropathic pain is essentially mediated through macrophages in peripheral inflammatory response,” GLIA, vol. 59, no. 2, pp. 231–241, 2011. View at Publisher · View at Google Scholar · View at Scopus
  37. Z.-Y. Chen, X.-W. Zhang, L. Yu et al., “Spinal toll-like receptor 4-mediated signalling pathway contributes to visceral hypersensitivity induced by neonatal colonic irritation in rats,” European Journal of Pain, vol. 19, no. 2, pp. 176–186, 2015. View at Publisher · View at Google Scholar · View at Scopus
  38. L. R. Watkins, M. R. Hutchinson, K. C. Rice, and S. F. Maier, “The “Toll” of opioid-induced glial activation: improving the clinical efficacy of opioids by targeting glia,” Trends in Pharmacological Sciences, vol. 30, no. 11, pp. 581–591, 2009. View at Publisher · View at Google Scholar · View at Scopus
  39. M. R. Hutchinson, Y. Zhang, M. Shridhar et al., “Evidence that opioids may have toll-like receptor 4 and MD-2 effects,” Brain, Behavior, and Immunity, vol. 24, no. 1, pp. 83–95, 2010. View at Publisher · View at Google Scholar · View at Scopus
  40. S. S. Lewis, M. R. Hutchinson, Y. Zhang et al., “Glucuronic acid and the ethanol metabolite ethyl-glucuronide cause toll-like receptor 4 activation and enhanced pain,” Brain, Behavior, and Immunity, vol. 30, pp. 24–32, 2013. View at Publisher · View at Google Scholar · View at Scopus
  41. T. Takahashi, K. Okubo, S. Kojima et al., “Antihyperalgesic effect of buprenorphine involves nociceptin/orphanin FQ peptide-receptor activation in rats with spinal nerve injury-induced neuropathy,” Journal of Pharmacological Sciences, vol. 122, no. 1, pp. 51–54, 2013. View at Publisher · View at Google Scholar · View at Scopus
  42. C. Acosta and A. Davies, “Bacterial lipopolysaccharide regulates nociceptin expression in sensory neurons,” Journal of Neuroscience Research, vol. 86, no. 5, pp. 1077–1086, 2008. View at Publisher · View at Google Scholar · View at Scopus